Prediabetes is a reversible phase of glycemic dysregulation that occurs before type 2 diabetes (T2D). It is therefore important to take in charge prediabetics before they reach diabetic stage. PEP2DIA® is a unique patented dairy bioactive that acts on the main factors leading to T2D.
(2022). Preclinical Study and Clinical Correlation of The Effect of PEP2DIA® Dose. Egyptian Society of Diabetes and Lipidology Journal, 2(1), -. doi: 10.21608/esdlj.2022.455714
MLA
. "Preclinical Study and Clinical Correlation of The Effect of PEP2DIA® Dose", Egyptian Society of Diabetes and Lipidology Journal, 2, 1, 2022, -. doi: 10.21608/esdlj.2022.455714
HARVARD
(2022). 'Preclinical Study and Clinical Correlation of The Effect of PEP2DIA® Dose', Egyptian Society of Diabetes and Lipidology Journal, 2(1), pp. -. doi: 10.21608/esdlj.2022.455714
VANCOUVER
Preclinical Study and Clinical Correlation of The Effect of PEP2DIA® Dose. Egyptian Society of Diabetes and Lipidology Journal, 2022; 2(1): -. doi: 10.21608/esdlj.2022.455714
)
